BPG is committed to discovery and dissemination of knowledge
Citation
Chen JQ, Lan X. Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers: Feasible or not feasible? World J Gastroenterol 2025; 31(10): 100771 [PMID: 40093676 DOI: 10.3748/wjg.v31.i10.100771]
Please LOGIN to submit a new comment.